Rezolute (previously AntriaBio) Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Rezolute (previously AntriaBio)'s estimated annual revenue is currently $12.9M per year.(i)
  • Rezolute (previously AntriaBio)'s estimated revenue per employee is $155,000

Employee Data

  • Rezolute (previously AntriaBio) has 83 Employees.(i)
  • Rezolute (previously AntriaBio) grew their employee count by 38% last year.

Rezolute (previously AntriaBio)'s People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
VP & Head Clinical OperationsReveal Email/Phone
3
VP New Product PlanningReveal Email/Phone
4
VP Clinical OperationsReveal Email/Phone
5
VP, QualityReveal Email/Phone
6
VP, Drug Discovery and Pharmaceutical SciencesReveal Email/Phone
7
VP and Head QualityReveal Email/Phone
8
VP & Head FinanceReveal Email/Phone
9
Director Quality ComplianceReveal Email/Phone
10
Associate Director MSAT, Upstream Drug SubstanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Rezolute (previously AntriaBio)?

Rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases. For more information, visit: www.rezolutebio.com.

keywords:N/A

N/A

Total Funding

83

Number of Employees

$12.9M

Revenue (est)

38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Rezolute (previously AntriaBio) News

2022-04-17 - Rezolute (NASDAQ:RZLT) Stock Rating Upgraded by Zacks ...

Rezolute, Inc., formerly known as AntriaBio, Inc., is based in LOUISVILLE, United States. “ Get Rezolute alerts: Separately, Roth Capital lifted...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.3M838%$11M
#2
$16.8M83-12%N/A
#3
$20.8M83-2%N/A
#4
$12.2M84N/AN/A
#5
$17.6M84N/AN/A